{"id":"NCT00339183","sponsor":"Amgen","briefTitle":"Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone","officialTitle":"A Randomized, Multicenter Phase 3 Study to Compare the Efficacy of Panitumumab in Combination With Chemotherapy to the Efficacy of Chemotherapy Alone in Patients With Previously Treated Metastatic Colorectal Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06-30","primaryCompletion":"2009-04-01","completion":"2010-11-01","firstPosted":"2006-06-20","resultsPosted":"2014-05-06","lastUpdate":"2022-09-23"},"enrollment":1186,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Metastatic Colorectal Cancer"],"interventions":[{"type":"DRUG","name":"Panitumumab","otherNames":["VectibixÂ®"]},{"type":"DRUG","name":"FOLFIRI","otherNames":[]}],"arms":[{"label":"Panitumumab Plus FOLFIRI","type":"EXPERIMENTAL"},{"label":"FOLFIRI Alone","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the treatment effect of panitumumab plus FOLFIRI compared to FOLFIRI alone as second line therapy for metastatic colorectal cancer.","primaryOutcome":{"measure":"Progression-free Survival (PFS)","timeFrame":"From randomization until the data cut-off date of 8 April 2008. Maximum follow-up time was 17 months.","effectByArm":[{"arm":"Wild-type KRAS - Panitumumab Plus FOLFIRI","deltaMin":5.9,"sd":null},{"arm":"Wild-type KRAS - FOLFIRI Alone","deltaMin":3.9,"sd":null},{"arm":"Mutant KRAS - Panitumumab Plus FOLFIRI","deltaMin":5,"sd":null},{"arm":"Mutant KRAS - FOLFIRI Alone","deltaMin":4.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0036"},{"comp":"OG002 vs OG003","p":"0.1448"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":13},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["24356622","20921462","30013091","31902066","29627309","26341920","26049686","22070868"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":232,"n":587},"commonTop":["Diarrhoea","Nausea","Neutropenia","Fatigue","Rash"]}}